Annual Non Current Assets
$18.42 M
+$1.94 M+11.80%
December 31, 2023
Summary
- As of February 8, 2025, VRNA annual long term assets is $18.42 million, with the most recent change of +$1.94 million (+11.80%) on December 31, 2023.
- During the last 3 years, VRNA annual non current assets has risen by +$16.71 million (+982.02%).
- VRNA annual non current assets is now at all-time high.
Performance
VRNA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$17.57 M
-$266.00 K-1.49%
September 30, 2024
Summary
- As of February 8, 2025, VRNA quarterly long term assets is $17.57 million, with the most recent change of -$266.00 thousand (-1.49%) on September 30, 2024.
- Over the past year, VRNA quarterly non current assets has dropped by -$266.00 thousand (-1.49%).
- VRNA quarterly non current assets is now -47.34% below its all-time high of $33.35 million, reached on September 30, 2020.
Performance
VRNA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
VRNA Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.8% | -1.5% |
3 y3 years | +982.0% | +2.9% |
5 y5 years | +371.2% | +273.8% |
VRNA Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +11.8% | -4.6% | +10.2% |
5 y | 5-year | at high | +982.0% | -47.3% | +1034.0% |
alltime | all time | at high | -100.0% | -47.3% | -100.0% |
Verona Pharma Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $17.57 M(-1.5%) |
Jun 2024 | - | $17.83 M(-1.3%) |
Mar 2024 | - | $18.07 M(-1.9%) |
Dec 2023 | $289.71 M(+19.2%) | $18.42 M(+15.5%) |
Sep 2023 | - | $15.94 M(-1.0%) |
Jun 2023 | - | $16.10 M(-1.0%) |
Mar 2023 | - | $16.25 M(-1.3%) |
Dec 2022 | $243.00 M(+42.9%) | $16.47 M(+0.3%) |
Sep 2022 | - | $16.42 M(+1.2%) |
Jun 2022 | - | $16.22 M(-0.8%) |
Mar 2022 | - | $16.36 M(-1.0%) |
Dec 2021 | $170.06 M(-16.0%) | $16.52 M(-3.2%) |
Sep 2021 | - | $17.07 M(+669.2%) |
Jun 2021 | - | $2.22 M(+43.3%) |
Mar 2021 | - | $1.55 M(-9.0%) |
Dec 2020 | $202.50 M(+272.9%) | $1.70 M(-94.9%) |
Sep 2020 | - | $33.35 M(+0.3%) |
Jun 2020 | - | $33.24 M(+501.8%) |
Mar 2020 | - | $5.52 M(+185.3%) |
Dec 2019 | $54.30 M(-40.3%) | $1.94 M(-58.8%) |
Sep 2019 | - | $4.70 M(+31.2%) |
Jun 2019 | - | $3.58 M(-4.7%) |
Mar 2019 | - | $3.76 M(-3.8%) |
Dec 2018 | $90.94 M(-22.7%) | $3.91 M(+15.8%) |
Sep 2018 | - | $3.37 M(+1.1%) |
Jun 2018 | - | $3.34 M(-6.3%) |
Mar 2018 | - | $3.57 M(+8.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $117.68 M(+117.7%) | $3.28 M(-0.4%) |
Sep 2017 | - | $3.29 M(+4.8%) |
Jun 2017 | - | $3.14 M(+9.2%) |
Dec 2016 | $54.05 M(+554.8%) | $2.88 M(+14.5%) |
Jun 2016 | - | $2.51 M(-25.2%) |
Dec 2015 | $8.26 M(-52.9%) | $3.36 M(+20.5%) |
Jun 2015 | - | $2.79 M(-4.3%) |
Dec 2014 | $17.52 M(+1145.1%) | $2.91 M(-7.1%) |
Jun 2014 | - | $3.13 M(+11.5%) |
Dec 2013 | $1.41 M(-25.5%) | $2.81 M(+11.1%) |
Jun 2013 | - | $2.53 M(-4.3%) |
Dec 2012 | $1.89 M(-53.5%) | $2.64 M(+5.9%) |
Jun 2012 | - | $2.49 M(+1.0%) |
Dec 2011 | $4.06 M(+27.1%) | $2.47 M(-2.4%) |
Jun 2011 | - | $2.53 M(+3.4%) |
Dec 2010 | $3.20 M(-38.4%) | $2.45 M(+3.2%) |
Jun 2010 | - | $2.37 M(-6.0%) |
Dec 2009 | $5.19 M(+40.5%) | $2.52 M(-1.4%) |
Jun 2009 | - | $2.55 M(+12.2%) |
Dec 2008 | $3.69 M(+24.8%) | $2.28 M(-26.6%) |
Jun 2008 | - | $3.10 M(+0.8%) |
Dec 2007 | $2.96 M(-37.5%) | $3.08 M(-1.1%) |
Jun 2007 | - | $3.11 M(+2.6%) |
Dec 2006 | $4.73 M(+177.6%) | $3.03 M(>+9900.0%) |
Jun 2006 | - | $0.00(0.0%) |
Dec 2005 | $1.71 M | $0.00(0.0%) |
Jun 2005 | - | $0.00 |
FAQ
- What is Verona Pharma annual long term assets?
- What is the all time high annual non current assets for Verona Pharma?
- What is Verona Pharma annual non current assets year-on-year change?
- What is Verona Pharma quarterly long term assets?
- What is the all time high quarterly non current assets for Verona Pharma?
- What is Verona Pharma quarterly non current assets year-on-year change?
What is Verona Pharma annual long term assets?
The current annual non current assets of VRNA is $18.42 M
What is the all time high annual non current assets for Verona Pharma?
Verona Pharma all-time high annual long term assets is $18.42 M
What is Verona Pharma annual non current assets year-on-year change?
Over the past year, VRNA annual long term assets has changed by +$1.94 M (+11.80%)
What is Verona Pharma quarterly long term assets?
The current quarterly non current assets of VRNA is $17.57 M
What is the all time high quarterly non current assets for Verona Pharma?
Verona Pharma all-time high quarterly long term assets is $33.35 M
What is Verona Pharma quarterly non current assets year-on-year change?
Over the past year, VRNA quarterly long term assets has changed by -$266.00 K (-1.49%)